Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19?

Coronavirus disease (COVID-19) caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing pandemic and presents a public health emergency. It has affected millions of people and continues to affect more, despite the tremendous social preventive measures. The therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagoor Meeran, M.F., Seenipandi, A., Javed, Hayate, Sharma, Charu, Hashiesh, Hebaallah Mamdouh, Goyal, Sameer N., Jha, Niraj Kumar, Ojha, Shreesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810623/
https://www.ncbi.nlm.nih.gov/pubmed/33490659
http://dx.doi.org/10.1016/j.heliyon.2020.e05703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810623/
https://www.ncbi.nlm.nih.gov/pubmed/33490659
http://dx.doi.org/10.1016/j.heliyon.2020.e05703

Ejemplares similares